LONDON - Cyclacel plc postponed its proposed dual listing on Nasdaq and the London Stock Exchange, citing market conditions, as Evolutec Group plc succeeded in getting its modest initial public offering away on London's Alternative Investment Market, raising £5.1 million (US$9.4 million) net of the £7.5 million net it had hoped for. (BioWorld International)
LONDON - Cyclacel plc postponed its proposed dual listing on Nasdaq and the London Stock Exchange, citing market conditions, as Evolutec Group plc succeeded in getting its modest initial public offering away on London's Alternative Investment Market, raising £5.1 million (US$9.4 million) net of the £7.5 million net it had hoped for. (BioWorld International)
LONDON - Microscience Ltd. pulled its £40 million (US$74.5 million) initial public offering on London's Alternative Investment Market after refusing to compromise on a £120 million to £140 million valuation. (BioWorld International)
